Sessa Capital IM, L.P.
Q1 2023 13F-HR Holdings
Net value change ($000)
+1,009,763
(62.1%)
New positions
14
Sold out positions
11
Turnover %
27.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ALLY | 197,891 | 448.9% |
| FCNCA | 158,509 | NEW |
| GEHC | 120,837 | 5320.9% |
| WBD | 107,321 | 48.3% |
| AIG | 73,040 | NEW |
| LH | 64,238 | NEW |
| TGNA | 61,186 | NEW |
| Provention Bio, Inc. | 56,713 | 36.1% |
| SCHW | 47,263 | NEW |
| Syneos Health, Inc. | 32,506 | NEW |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
206,710
(7.8% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|